Algocyte brings CBC monitoring into the patient's home, protecting clozapine adherence, reducing relapse risk and freeing community psychiatry capacity.
Patients must attend frequent in-person testing appointments to stay on clozapine.
Monitoring requirements create the single biggest barrier to adherence.
Testing, follow-up and treatment management live in separate systems.
Traditional pathways are resource-intensive and hard to expand.
Algocyte Proxima uses a finger prick or shoulder patch with a result in about 15 minutes. Automated reminders and longitudinal monitoring keep patients engaged with the therapy that's working.
Meet ProximaAI-driven longitudinal monitoring surfaces patients trending toward neutropenia early, so titration and escalation decisions happen on signal, not on a single value.
Inside Health HubCo-design the pathway with your clozapine and pharmacy leads.
EHR integration in development to route alerts to the MDT.
Devices ship to homes; remote onboarding in under an hour.
Joint review of adherence, ANC trends and avoided admissions.
Personal health intelligence, in one place you control.
Learn moreNHS oncology programs and dashboards with EHR integration in development.
Learn moreOutcome data for value-based contracts and lower acute spend.
Learn moreSponsor-supported oncology and decentralized trials.
Learn moreBook a 20-minute briefing with our clinical team to see Algocyte in action.